Archive for the ‘Gulf War Illness’ Category

Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak.

Tuesday, February 3rd, 2009

Neuroepidemiology. 2008 Jun 6;31(1):28-32. [Epub ahead of print]

Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak.

Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, Allen KD, Kasarskis EJ.

Department of Public Health Sciences and Institute for the Study of Health and Department of Neurology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.

Background: In follow-up to recent reports of an elevated risk of amyotrophic lateral sclerosis (ALS) among 1991 Gulf War veterans, we analyzed the distribution of disease onset times to determine whether the excess risk was time limited. Methods: This secondary analysis used data from a population-based series of ALS cases identified between 1991 and 2001 among the 2.5 million military personnel who were on active duty during the 1991 Gulf War. Annual standardized incidence ratios (SIR) were calculated for all cases and for those with disease onset before age 45 years. Results: Forty-eight of 124 cases occurred among those deployed to the Persian Gulf region during the war. The annual SIR for deployed military personnel did not demonstrate a monotonically increasing trend for either all cases (chi(2) = 0.11, d.f. = 1, p = 0.74) or for cases under 45 years of age at onset (chi(2) = 2.41, d.f. = 1, p = 0.12). The highest risk was observed in 1996, declining thereafter. Among military personnel who were not deployed to the Gulf region, the level of risk remained fairly constant during the 11-year period. Conclusions: The excess risk of ALS among 1991 Gulf War veterans was limited to the decade following the war. Copyright © 2008 S. Karger AG, Basel.

PMID: 18535397 [PubMed - as supplied by publisher]

Acetylcholinesterase inhibitors and Gulf War illnesses.

Wednesday, January 28th, 2009

Proc Natl Acad Sci U S A. 2008 Mar 10 [Epub ahead of print]

Acetylcholinesterase inhibitors and Gulf War illnesses.
Golomb BA.

Department of Medicine, University of California, San Diego, CA 92093-0995.

Increasing evidence suggests excess illness in Persian Gulf War veterans (GWV) can be explained in part by exposure of GWV to organophosphate and carbamate acetylcholinesterase inhibitors (AChEis), including pyridostigmine bromide (PB), pesticides, and nerve agents. Evidence germane to the relation of AChEis to illness in GWV was assessed. Many epidemiological studies reported a link between AChEi exposure and chronic symptoms in GWV. The link is buttressed by a dose-response relation of PB pill number to chronic symptoms in GWV and by a relation between avidity of AChEi clearance and illness, based on genotypes, concentrations, and activity levels of enzymes that detoxify AChEis. Triangulating evidence derives from studies linking occupational exposure to AChEis to chronic health symptoms that mirror those of ill GWV. Illness is again linked to lower activity of AChEi detoxifying enzymes and genotypes conferring less-avid AChEi detoxification. AChEi exposure satisfies Hill’s presumptive criteria for causality, suggesting this exposure may be causally linked to excess health problems in GWV.

PMID: 18332428 [PubMed - as supplied by publisher]